AZN — AstraZeneca Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
£198.21bn
Enterprise Value
£217.54bn
Revenue
$54.07bn

REG - AstraZeneca PLC - Director/PDMR Shareholding
04/12/2018 15:00Announcement
REG - AstraZeneca PLC - Block listing Interim Review
03/12/2018 16:00Announcement
REG - AstraZeneca PLC - Total Voting Rights
03/12/2018 16:00Announcement
REG - AstraZeneca PLC - Grünenthal Agreement for Nexium, Vimovo Completed
03/12/2018 07:05Announcement
REG - AstraZeneca PLC - US FDA grants Fasenra ODD for EGPA
26/11/2018 07:05Announcement
REG - AstraZeneca PLC - AstraZeneca provides update on Phase III MYSTIC
16/11/2018 07:05Announcement
REG - AstraZeneca PLC - AstraZeneca to divest US Synagis rights to Sobi
13/11/2018 07:05Announcement
REG - AstraZeneca PLC - US FDA accepts regulatory submission for Lynparza
12/11/2018 07:10Announcement
REG - AstraZeneca PLC - Farxiga significantly reduced hospitalisation for
12/11/2018 07:05Announcement
REG - AstraZeneca PLC - AZN: Year-to-Date and Q3 2018 Results
08/11/2018 07:05Announcement
REG - AstraZeneca PLC - Divestment of rights to Covis Pharma
06/11/2018 07:05Announcement
REG - AstraZeneca PLC - Total Voting Rights
01/11/2018 15:00Announcement
REG - AstraZeneca PLC - Additional financial information-Grünenthal deal
31/10/2018 09:45Announcement
REG - AstraZeneca PLC - Grünenthal Agreement for rights to Nexium, Vimovo
30/10/2018 07:05Announcement
REG - AstraZeneca PLC - AstraZeneca Extends Innate Pharma Collaboration
23/10/2018 07:05Announcement
REG - AstraZeneca PLC - Lynparza shows 70% reduction in PFS ovarian cancer
22/10/2018 07:05Announcement
REG - AstraZeneca PLC - CHMP positive opinion Bevespi Aerosphere
19/10/2018 13:10Announcement
REG - AstraZeneca PLC - FDA Orphan Drug for Lynparza in pancreatic cancer
16/10/2018 07:05Announcement
REG - AstraZeneca PLC - Total Voting Rights
01/10/2018 15:00Announcement
REG - AstraZeneca PLC - Atacand Agreement with Cheplapharm Completed
01/10/2018 07:05Announcement